Nov 7 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS Q3 2018 RESULTS
* Q3 EARNINGS PER SHARE $0.03 FROM CONTINUING OPERATIONS
* Q3 REVENUE $4.8 MILLION VERSUS $10 MILLION
* Q3 EARNINGS PER SHARE VIEW $0.10, REVENUE VIEW $6.9 MILLION -- THOMSON REUTERS I/B/E/S
* CIPHER PHARMACEUTICALS - IN Q4 2018, EXPECTS PRESCRIPTIONS FOR ABSORICA TO INCREASE VERSUS Q3 2018 DUE TO SEASONALITY OF PRODUCT